Dopa, 3-O-methyldopa, and metabolites in urine during oral L-3-O-methyldopa therapy.
D000284:Administration, Oral; D001322:Autoanalysis; D002395:Catecholamines / Q000652:urine; D003640:Dealkylation; D003653:Decarboxylation; D004295:Dihydroxyphenylalanine / Q000652:urine*; D005470:Fluorometry; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D007773:Lactates / Q000652:urine; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000652:urine; D008750:Methyldopa / Q000008:administration & dosage / Q000627:therapeutic use* / Q000652:urine; D010300:Parkinson Disease / Q000188:drug therapy*; D014642:Vanilmandelic Acid / Q000652:urine
D002395:Catecholamines; D007773:Lactates; D008734:Methoxyhydroxyphenylglycol; D014642:Vanilmandelic Acid; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D006719:Homovanillic Acid